Nucleic Acid Structural Analysis via Methyltransferase Barcoding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for determining genomic sequence information focus on local sequence data, neglecting structural genomic context, making it difficult to access genomic rearrangements, duplications, and other structural sequence information, which are crucial for understanding genetic health and disease states.

Innovation Solution

The method involves processing a double-stranded DNA sample to create sequence-specific labels, allowing for the analysis of nucleic acid biopolymers without breaking them into individual nucleic acids, using techniques like methyltransferase labeling to generate 'barcodes' that indicate relative positions of specific sequences, enabling the preservation of native genomic structures and direct analysis of large intact genomic molecules.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If conventional sequencing methods are used to obtain local sequence information, then sequencing cost and ease of obtaining sequence data are improved, but structural genomic context and structural sequence information are lost

Engineering Contradiction:
Improveease of obtaining sequence dataVSAvoidstructural genomic context
Core Design Contradiction:
Ease of manufactureVSLoss of information

Solution Approach 1:

The method segments the genome into long intact molecules (e.g., BACs, cosmids, or chromosomal segments) that maintain their native structure, rather than fragmenting them into small reads. This allows simultaneous acquisition of local sequence information through sequencing and structural context through physical mapping of these intact molecules.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention adds a spatial dimension by physically mapping sequence information along the length of intact DNA molecules using techniques like FISH or chromosomal walking. This transforms 1D sequence data into 2D spatial information that preserves genomic context and structural relationships.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Adaptability or versatility

If cytogenetic methods like karyotyping or FISH are used to visualize genomic structural information, then global view of structural information is obtained, but resolution and sensitivity for detecting small sequence motifs or lesions are reduced

Engineering Contradiction:
Improveglobal view of genomic structureVSAvoidresolution for detecting small sequence motifs
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The method segments the genome into large intact molecules that can be individually analyzed, allowing high-resolution detection of small features within the context of the overall genome structure. This enables simultaneous global and local analysis.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses physical mapping techniques as intermediaries between cytogenetic methods and molecular sequencing. These techniques (FISH, chromosomal walking) provide a bridge that maintains both the global structural view and the high resolution needed to detect small sequence motifs.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If DNA is fragmented into individual nucleic acids for analysis, then sequencing and analysis can be performed, but native genomic structures and structural information are destroyed

Engineering Contradiction:
Improvesequencing throughputVSAvoidnative genomic structure
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

Instead of fragmenting DNA into small reads that lose structural context, the method segments the genome into large intact molecules (kilobase to megabase scale) that maintain their native structure during analysis. This allows high productivity while preserving structural information.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention changes the size parameter of DNA fragments from nanoscale reads to microscale intact molecules, enabling simultaneous sequencing and structural analysis without fragmentation. This parameter change allows the DNA to maintain its native conformation during processing.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for rapid and economical determination of nucleic acid structural information, providing detailed genomic and epigenomic insights without fragmenting DNA, thus improving the resolution and accuracy of genomic analysis and reducing sequencing costs.

Implementation Method 1

processing a double-stranded DNA sample to create sequence-specific labels, allowing for the analysis of nucleic acid biopolymers without breaking them into individual nucleic acids, using techniques like methyltransferase labeling to generate 'barcodes' that indicate relative positions of specific sequences

Methodology Applied
Scientific EffectMethyltransferase labeling: Enzyme

Data Source

PatentUS12054771B2Methods of determining nucleic acid structural information
Publication Date: 2024.08.06 BIONANO GENOMICS INC
  • US12054771B2 patent drawing
  • US12054771B2 patent drawing
  • US12054771B2 patent drawing

AI summary

Methods of double-stranded nucleic acid sequence determination and assembly that are able to identify insertions, deletions, repeat region sizes and genomic rearrangements, for example, are disclosed herein, which can use relatively large labeled nucleic acid fragments to analyze the structure of even larger genetic regions. In some embodiments these methods involve the use of certain parameters which unexpectedly improve overall method performance. In some embodiments these methods involve sample labeling that does not result in the formation of single-stranded nucleic acid fragment labeling intermediaries.